Differences Between COPD and Emphysema
Aug 05, 2022
Source: Cainiu Health
Dr. Guo Xiheng
Introduction
COPD encompasses chronic bronchitis and emphysema. Clinically, it primarily manifests as cough, sputum production, chest tightness, and wheezing; in severe cases, dyspnea and respiratory failure may occur. Pulmonary function tests in COPD patients show a marked decline. Pathologically, emphysema is characterized by reduced elasticity of the airways distal to the terminal bronchioles. In emphysema patients, pulmonary function testing primarily reveals an increased residual volume.
In modern life, people face considerable pressure from daily living, studying, and working—often neglecting physical exercise, which leads to a decline in immunity. Combined with poor dietary habits, this contributes to numerous health conditions. Chronic obstructive pulmonary disease (COPD) and emphysema are relatively common respiratory disorders. So, what are the differences between COPD and emphysema?
Differences Between COPD and Emphysema
COPD encompasses both chronic bronchitis and emphysema. Clinically, it primarily manifests as cough, sputum production, chest tightness, and wheezing; in severe cases, patients may develop dyspnea and respiratory failure. Pulmonary function tests in COPD patients show marked deterioration. In contrast, the pathological hallmark of emphysema is reduced elasticity of the airways distal to the terminal bronchioles. Pulmonary function testing in emphysema patients typically reveals increased residual air volume. In summary, while COPD and emphysema are closely interrelated, they also exhibit distinct differences. Regardless of the diagnosis, prompt medical evaluation and treatment at a hospital are essential upon confirmation.
Treatment for COPD and emphysema is divided into two phases: stable phase and acute exacerbation phase. During the stable phase, patients should quit smoking first and consistently perform respiratory muscle training. Oxygen therapy may be administered as clinically indicated, and long-acting bronchodilators should be used regularly to slow the decline in lung function. If symptoms persist, adjunctive therapies—including short-term, low-dose intravenous corticosteroids and nebulized inhalation treatments—may be employed. Through these comprehensive therapeutic strategies, patients can effectively alleviate clinical symptoms, improve quality of life, and extend survival.
Patients are advised to strengthen their constitution through regular physical activity and maintain a balanced, nutritious diet, while cultivating healthy lifestyle habits. We hope this information proves helpful to you.
